Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Logem

Logem
In stock
25mg · 50mg · 100mg · 200mg
from A$72.72
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$87.27A$72.72
A$2.42 per tablet

In brief

  • Logem (lamotrigine) is supplied in pharmacies in New Zealand and Australia and via online suppliers; the medicine is legally prescription-only, but in practice some pharmacies or online vendors may supply Logem without a prescription or receipt — availability varies by seller and should be approached with caution.
  • Logem is used to treat epilepsy (partial and some generalized seizures) and to help prevent depressive episodes in bipolar disorder. It works mainly by stabilising neuronal membranes through inhibition of voltage‑gated sodium channels and reducing release of excitatory neurotransmitters.
  • Usual dosing begins with a low titration (commonly 25 mg once daily for 1–2 weeks then gradually increased); typical maintenance doses are 100–200 mg per day (divided), with higher doses (up to 200–400 mg/day) sometimes used when taken with enzyme inducers and lower doses required if taken with valproate — individual dosing depends on concomitant medicines, age and liver/kidney function.
  • Administration is oral: standard tablets, dispersible/chewable tablets, and extended‑release (XR) tablets are available; starter/titration packs are used to guide gradual dose increases.
  • Blood levels typically peak within about 1–3 hours after an immediate‑release dose, but clinical benefits (and safe use) require gradual titration so meaningful therapeutic effect may take days to several weeks.
  • Duration of action is generally around 24 hours with regular dosing; the elimination half‑life is roughly 25–33 hours in many people (longer when combined with valproate, shorter with enzyme inducers); XR formulations support once‑daily dosing.
  • Avoid excessive alcohol while taking Logem — alcohol can worsen dizziness, drowsiness and may increase seizure risk; use caution and do not drink heavily.
  • The most common side effec are headache, dizziness, nausea, sleep disturbances and rash; a rash can occasionally be severe (Stevens–Johnson syndrome/toxic epidermal necrolysis) so slow titration and prompt medical attention for any skin reaction are essential.
  • Would you like to try logem without a prescription?

Basic Logem Information

  • INN (International Nonproprietary Name): Lamotrigine
  • Brand Names Available In Australia: Lamictal; Arrow‑Lamotrigine; Logem; Lamictal XR (global originator and generics are listed in regional product registries)
  • ATC Code: N03AX09
  • Forms & Dosages: Dispersible/chewable tablets 25 mg, 50 mg, 100 mg; Standard tablets 25 mg, 50 mg, 100 mg; Extended‑release (XR) tablets 25 mg, 50 mg, 100 mg, 200 mg, 250 mg, 300 mg; Starter/titration packs (5‑week sets)
  • Manufacturers In Australia: Originator GSK (Lamictal); generic suppliers include Teva, Arrow and Mylan/Logem (regional suppliers listed)
  • Registration Status In Australia: Not specified (refer to ARTG and TGA product information for current registered products)
  • OTC / Rx Classification: Prescription Only (Rx)

Critical Warnings, Restrictions And Patient Protection (Safety First)

High‑Risk Groups (Elderly, Pregnancy, Chronic Illness)

Known hypersensitivity to lamotrigine or a history of severe skin reaction such as Stevens–Johnson syndrome or toxic epidermal necrolysis is an absolute contraindication and requires immediate cessation and urgent medical review.

Pregnant people need specialist review because lamotrigine doses often require adjustment during pregnancy and postpartum and plasma levels should be monitored to avoid breakthrough seizures.

Start low and titrate slowly in children and the elderly to reduce risk of adverse effects, particularly rash.

Severe hepatic impairment or advanced renal impairment requires dose reduction and closer clinical review.

Monitor for any new rash, fever, mucosal lesions or systemic symptoms; suspected serious rash requires immediate stopping and urgent medical attention.

  • Checklist For Patients:
  • Watch for rash, blistering, peeling skin, fever or mouth sores and seek urgent care if these occur.
  • Inform prescriber if planning pregnancy, currently pregnant or breastfeeding; arrange plasma level monitoring as advised.
  • Follow the prescribed titration schedule exactly, especially starter or titration packs.
  • Attend regular reviews as scheduled and report any new medical conditions or new medicines.

Clinical authority: counselling should reference the product information and TGA guidance and consider PBS criteria where relevant.

Interaction With Activities (Driving, Workplace Safety Under Australian Law)

Lamotrigine can cause dizziness, blurred vision and ataxia which may impair your ability to drive or operate heavy machinery.

Avoid driving or operating machinery until you know how lamotrigine affects you and your dose is stable.

Employers and licensing bodies should be advised if seizures are not controlled and occupational assessments may be required.

Follow AustRoads guidance and local occupational health advice regarding fitness to drive after a change in seizure control or medication.

Q&A — Can I Drive After Taking It In Australia?

Short answer: Not until you are certain it does not impair you.

  • Avoid driving after starting lamotrigine or changing dose until you are symptom‑free and stable on the new dose.
  • Discuss fitness to drive with your neurologist or GP and follow AustRoads guidance if you have had recent seizures.
  • If you experience dizziness, blurred vision or ataxia, do not drive and seek medical advice.
  • Keep a record of seizure control and medication changes to support licence reviews if requested by authorities or employers.

Usage Basics

INN, Brand Names Available In Australia

The International Nonproprietary Name (INN) is lamotrigine.

Brand presentations in regional registries include Lamictal, Arrow‑Lamotrigine and Logem, with Lamictal XR listed globally for extended‑release formulations.

Tablets commonly come in 25 mg, 50 mg and 100 mg strengths, and starter titration packs are used to reduce rash risk.

Brand vs Generic
Brand refers to originator names such as Lamictal; generic refers to equivalent lamotrigine products supplied by companies like Arrow, Teva or Mylan/Logem.
Tablet Strengths
Typical strengths are 25 mg, 50 mg and 100 mg for immediate‑release tablets; XR tablets are available in higher strengths internationally.
Starter Titration Pack
Starter packs provide a 5‑week schedule of escalating doses to reduce the risk of serious skin reactions.

Legal Classification (TGA‑Approved, PBS‑Listed)

Lamotrigine is prescription‑only (Rx) and is approved for epilepsy and for prevention of depressive episodes in bipolar disorder in many jurisdictions.

Check TGA product information and the PBS schedule for current Australian indications, subsidy rules and authority requirements.

INN ATC Code Prescription Status Common Package Sizes
Lamotrigine N03AX09 Prescription Only (Rx) Tablets 25 mg, 50 mg, 100 mg; XR bottles of 30; Starter/titration packs

Dosing Guide

Standard Regimens (PBS Reference Dosing)

Treatment is started with slow titration using starter packs to minimise rash risk.

For monotherapy a common initial regimen is 25 mg once daily for two weeks, with stepwise increases towards a target maintenance dose of 100–200 mg per day in divided doses.

When lamotrigine is used with enzyme inducers maintenance doses may be higher, often 200–400 mg per day.

When combined with valproate doses are lower because valproate inhibits lamotrigine metabolism and increases rash risk.

Starter packs usually provide a five‑week schedule designed to reduce cutaneous reaction risk.

Week Monotherapy Typical Dose With Valproate With Enzyme Inducer
1–2 25 mg once daily 25 mg every other day (or lower per product info) 25 mg once daily
3–4 50 mg daily (often split 25 mg twice daily) 25 mg once daily 50 mg twice daily
5–6 100 mg/day in divided doses 50 mg once daily 100–200 mg/day depending on response
Maintenance 100–200 mg/day divided Lower maintenance dose; adjust carefully 200–400 mg/day may be needed

Adjustments For Comorbidities

Children follow weight‑based dosing and slower titration schedules as per product information.

Elderly patients should start at the low end of the dose range and titrate cautiously while monitoring for dizziness and ataxia.

Hepatic impairment requires dose reduction and slower up‑titration; severe renal impairment calls for close monitoring and possible dose change.

Q&A — What If I Miss A Dose?

  • Take the missed dose as soon as you remember unless the next dose is due soon.
  • Do not double the dose to catch up.
  • If you miss several doses, contact your pharmacist or prescriber for advice before resuming.
  • If unsure, seek pharmacist guidance rather than guessing.

Interaction Chart

Food And Drinks (Alcohol, Australian Diet Context)

There are no major food interactions with lamotrigine reported in product information.

Alcohol can increase sedation, dizziness and may elevate seizure risk, so advise moderation particularly during titration or when starting treatment.

Caffeine does not have a clinically significant interaction but may worsen insomnia or tremor in sensitive patients.

  • Lifestyle Checklist:
  • Limit alcohol while starting or changing lamotrigine dose and if experiencing dizziness.
  • Maintain hydration in hot climates to reduce dizziness risk, especially during summer in Australia.
  • Take tablets with or without food according to personal tolerance; dispersible tablets should be handled per instructions.

Common Drug Conflicts

Valproate markedly inhibits lamotrigine metabolism leading to higher lamotrigine levels and increased rash risk, so lamotrigine doses are reduced and titration slowed when combined with valproate.

Enzyme inducers such as carbamazepine, phenytoin, phenobarbital and rifampicin lower lamotrigine concentrations and often necessitate higher maintenance doses.

Hormonal contraceptives can alter lamotrigine levels; dose adjustments may be needed on starting or stopping combined oral contraceptives.

Drug/Class Effect On Lamotrigine Counselling Points
Valproate Inhibits metabolism → increased lamotrigine levels Halve lamotrigine dose and use slower titration; monitor closely for rash
Carbamazepine / Phenytoin / Phenobarbital Induce metabolism → lower lamotrigine levels May need higher maintenance dose; monitor seizure control
Rifampicin Strong inducer → significantly lowers levels Specialist review for dose adjustment
Oral Contraceptives Can change lamotrigine clearance Monitor for mood/seizure changes when starting/stopping; adjust dose if required

User Reports & Trends (Australian Patient Feedback)

Australian patients commonly report good seizure control and mood stabilisation when lamotrigine is effective for their condition.

Initial side effects reported include dizziness, nausea and sleep disturbance, and worry about rash is a frequent theme.

Price sensitivity and preference for PBS‑subsidised generics is common in consumer feedback.

Rural patients sometimes report refill delays, while urban patients note fast turnarounds through major pharmacy chains.

  • Efficacy: Many report reduced seizure frequency or better mood stability on lamotrigine.
  • Side Effects: Dizziness, nausea, sleep changes and occasional headaches during titration.
  • Titration Frustration: Some find the slow starter pack schedule inconvenient but understand the safety reason.
  • Rash Anxiety: Concern about skin reactions leads to heightened vigilance and early contacts with pharmacists.
  • PBS Paperwork: Authority prescriptions or repeats can be a hurdle for some patients.
  • Availability: Generic preference and online ordering are popular, especially for routine refills.
Reported Effect Relative Frequency Recommended Pharmacist Response
Seizure Reduction Common Reinforce adherence and continue monitoring
Dizziness/Nausea Common During Titration Advise on timing with food and slower dose increases; review if persistent
Rash Concerns Moderate Counsel on immediate stopping and urgent review if rash appears

Access & Purchase Options In Australia

National Chains (Chemist Warehouse, Priceline, TerryWhite Chemmart)

Lamotrigine is dispensed through community pharmacies across Australia including major chains that commonly stock generics and can source brand stock.

Price varies by brand and PBS subsidy status so Australians commonly compare prices across chains and independents.

Pharmacy Type Typical Availability Likely Wait Times (Metro vs Rural)
Major Chain (in‑store) Generics usually available; starter packs commonly stocked Metro: Same day to 48 hours; Rural: 2–5 days
Independent Pharmacy Can order specific brands; may have limited immediate stock Metro: 24–72 hours; Rural: 3–7 days
Online Pharmacy Generics and some brands available; requires valid prescription Metro: 2–7 days delivery; Rural: 5–14 days delivery
  • What To Bring To The Pharmacy: valid prescription, concession card if eligible, PBS paperwork, and an up‑to‑date list of current medicines.

Online Pharmacies And Telehealth E‑Prescriptions

E‑prescriptions and telehealth are widely used in Australia and many pharmacies accept digital scripts and offer delivery to rural addresses.

Always confirm the online supplier is TGA‑registered and that they require a valid prescription before dispensing prescription medicines.

For patients in remote areas, arrange repeat dispensing or longer‑term supply planning to avoid gaps in treatment.

Pharmacists can provide counselling by phone or video; ensure pharmacist contact details are provided with online orders.

Mechanism & Pharmacology

Simplified Explanation

Lamotrigine stabilises neuronal membranes by inhibiting voltage‑sensitive sodium channels and reducing glutamate release, which lowers excitatory neurotransmission.

These actions make lamotrigine useful for focal and generalised seizures and for prevention of depressive episodes in bipolar disorder.

Sodium Channel Blocker
Reduces repetitive neuronal firing and glutamate release.
Glutamate Modulation
Decreases excitatory neurotransmitter availability.
ATC Code
N03AX09 (antieleptic, other antiepileptics).

Clinical Terms

Lamotrigine is well absorbed orally and has a variable half‑life which shortens with enzyme inducers and lengthens with valproate co‑administration.

It is metabolised in the liver and requires dose adjustments in hepatic impairment.

Therapeutic drug monitoring is not routine but is recommended in pregnancy, suspected toxicity or adherence concerns.

Parameter Summary
Absorption Well absorbed orally
Metabolism Hepatic metabolism; interactions alter clearance
Elimination Renal metabolites; clearance affected by enzyme inducers/inhibitors
Monitoring Triggers Pregnancy, toxicity, adherence worries

Indications & Off‑Label Uses

Approved Indications By TGA

Typical approved uses include adjunctive or monotherapy for partial and generalised seizures and prevention of depressive episodes in bipolar disorder.

Check current TGA product information for the exact Australian indications and age limits for each registered product.

  • First‑Line/Second‑Line Scenarios: focal epilepsies where cognitive profile is important; maintenance for bipolar depressive relapse prevention.

Off‑Label Uses In Australian Clinical Practice

Occasionally lamotrigine is used off‑label for neuropathic pain or refractory mood disorder when other agents have failed, although evidence is limited.

Off‑label use should be guided by specialist review, documented rationale and informed consent that includes discussion of risks such as rash.

  • Prescriber Checklist For Off‑Label Use: evidence summary, monitoring plan, informed consent and specialist involvement where appropriate.

Key Clinical Findings (Australian And International Evidence 2022–2026)

Recent systematic reviews and trials continue to support lamotrigine’s efficacy for partial seizures and for preventing depressive episodes in bipolar disorder.

Lamotrigine generally has a lower cognitive side‑effect profile compared with some older antiepileptics.

Safety data consistently reinforce the importance of slow titration to reduce the ongoing risk of serious cutaneous reactions, particularly in children and with valproate combination therapy.

Australian cohort data align with international findings regarding dose adjustments in pregnancy and the need for plasma level monitoring.

  • Major Takeaway: Slow titration remains the cornerstone of safety to minimise serious skin reactions.
  • Major Takeaway: Valproate co‑administration requires dose reduction of lamotrigine and closer monitoring.
  • Major Takeaway: Pregnancy needs proactive management and plasma level checks.
Evidence Strength Clinical Action
Strong Use lamotrigine as first‑line for specific focal epilepsies where appropriate
Moderate Consider off‑label use only with specialist oversight

When publishing, link to TGA and peer‑reviewed sources such as product information and systematic reviews for transparency.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Typical Indications Major Risks Monitoring PBS Notes
Levetiracetam (Keppra) Adjunctive therapy for focal and generalised seizures Behavioural changes, irritability Clinical review for mood/behaviour PBS‑listed options available
Valproate (Depakote) Generalised seizures, bipolar disorder High teratogenic risk in pregnancy Liver tests, blood counts, pregnancy counselling PBS with strict pregnancy counselling requirements
Carbamazepine (Tegretol) Focal seizures, trigeminal neuralgia Hyponatraemia, rash, blood dyscrasias Serum levels, blood counts PBS‑listed
Oxcarbazepine (Trileptal) Focal seizures Hyponatraemia Electrolytes, clinical monitoring PBS‑listed alternatives available

Pros And Cons Checklist

  • Consider seizure type suitability before switching between lamotrigine and alternatives.
  • Discuss fertility and pregnancy implications, notably valproate’s teratogenicity.
  • Assess interaction burden: lamotrigine has moderate interactions versus others.
  • Factor in monitoring frequency and patient lifestyle (driving, work safety).
  • Make decisions collaboratively with specialists for complex cases.

Common Questions (Pharmacy Consultation FAQs)

  • Can I switch to a generic? — Yes; generics such as Arrow‑Lamotrigine or Logem are therapeutically equivalent but check packaging and titration continuity.
  • How long to titrate? — Starter packs commonly cover five weeks to reach maintenance while minimising rash risk.
  • When to seek emergency care for rash? — Any widespread blistering, peeling, mucosal sores or systemic symptoms require immediate discontinuation and urgent review.
  • What about pregnancy? — Discuss with your prescriber; dose changes and plasma monitoring are often needed.
  • Do oral contraceptives interact? — Yes; monitor lamotrigine levels and clinical response when starting or stopping hormonal contraception.
  • Missed doses? — Take as soon as remembered unless near next dose; do not double up.

Pharmacist Decision Checklist — Red Flags That Need Immediate Referral:

  • Severe rash, mucosal involvement or fever.
  • Sustained unsteadiness, marked visual disturbance or altered consciousness.
  • Pregnancy without specialist plan or missed specialist follow‑up during dose changes.

Price & Access Comparison

Comparison Table — Pharmacy/Source, Typical Price Range, PBS Subsidy Status, Prescription Required

Source Availability (Brand/Generic) Typical Cash Price Range (Estimate) PBS Subsidy Prescription Required
Chemist Warehouse Generics commonly stocked $10–$40 (varies by pack and subsidy) Yes, where PBS criteria met Yes
Priceline Brand and generics available $12–$45 Yes Yes
TerryWhite Chemmart Generics and brand on request $15–$50 Yes Yes
Independent Pharmacies May order specific brands $12–$60 Yes Yes
Online TGA‑Registered Suppliers Generics; confirm product and supplier $10–$60 (plus delivery) Varies Yes (valid prescription required)

Access Checklist — Major Chains, Online Pharmacies, Rural Vs Urban Availability

  • Confirm prescription validity and whether an authority script is required for PBS subsidy.
  • Bring concession card to reduce cost where eligible.
  • Ask about repeats and arrange scheduled dispensings for remote locations.
  • Record pharmacist contact details for counselling after online orders or deliveries.
  • For starter packs, verify continuity of supply before finishing the pack to avoid interruptions.

Registration & Regulation

TGA Approval

Lamotrigine products are prescription medicines regulated by the Therapeutic Goods Administration (TGA).

Consult the Australian Register of Therapeutic Goods (ARTG) for current registered products and sponsor details.

ARTG
Database of registered therapeutic goods in Australia.
CMI
Consumer Medicines Information leaflet supplied with registered products.
SmPC / Product Information
Detailed prescribing and safety information for clinicians and pharmacists.

PBS Subsidy Details

PBS listings determine subsidy and patient cost and some indications may require authority prescriptions.

Check PBS schedules for current product listings and any restriction that affect dispensing.

Regional product lists such as PHARMAC in New Zealand identify brands like Lamictal, Arrow and Logem as funded regionally.

Storage & Handling (Household And Pharmacy)

Household Storage In Australian Climate (Heat/Humidity)

Store lamotrigine below 25°C and protect from light and moisture.

Avoid storing tablets in bathrooms or cars during hot or humid weather; use a cool, dry cupboard instead.

Keep medication in original packaging to protect dispersible tablets and to retain expiry and batch information.

  • Household Checklist: keep out of reach of children, do not store in cars, check expiry dates, retain child‑resistant packaging where applicable.

Cold‑Chain Handling For Pharmacies

Lamotrigine does not require cold‑chain transport or refrigerated storage.

Pharmacies must store product at controlled room temperature, maintain secure stock handling and rotate starter packs and blister packs per normal pharmacy practice.

Track batch numbers and monitor for recalls as per TGA guidance.

Guidelines For Proper Use (Australian Pharmacist Counselling Style)

Counselling Checklist For Pharmacists

  • Explain the purpose of therapy (epilepsy or bipolar disorder prevention) and expected timeline for benefit.
  • Emphasise slow titration using starter packs and the reason for it — to reduce serious skin reaction risk.
  • Describe rash signs that require immediate stopping and urgent care.
  • Review interactions with valproate, enzyme inducers and hormonal contraception.
  • Give missed‑dose instructions and clear driving/safety advice.
  • Provide written Consumer Medicines Information (CMI) or PBS factsheet and document counselling in the patient record.
  • Offer a laminated patient wallet card containing dose schedule, emergency contact and allergy alert.

Patient Advice From PBS And National Health Authorities

Advise patients to follow prescriber instructions, maintain scheduled follow‑ups and report adverse events via the TGA adverse event reporting system.

If switching brands or facing supply interruptions, contact the prescriber and pharmacist to avoid abrupt cessation.

For additional support, signpost patients to epilepsy foundations and perinatal mental health services as appropriate.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Geelong Victoria 9-14 days
Townsville Queensland 14-21 days
Cairns Queensland 14-21 days

Note: Delivery times are estimates and may vary by supplier, location and current demand.

In our online pharmacy, logem is available with a valid prescription and can be delivered discreetly across Australia within the stated delivery windows.

Always confirm current PBS listings and local pharmacy stock when planning ongoing treatment.

Related products